Kelly Fahnoe

Structural comparison of chromosomal and exogenous dihydrofolate reductase from <i>Staphylococcus aureus</i> in complex with the potent inhibitor trimethoprim

H. Heaslet, Melissa S. Harris, Kelly Fahnoe et al. · Proteins Structure Function and Bioinformatics · 2009 · 132 citations

Clinically Relevant Gram-Negative Resistance Mechanisms Have No Effect on the Efficacy of MC-1, a Novel Siderophore-Conjugated Monocarbam

Craig J. McPherson, Lisa Aschenbrenner, Brian M. Lacey et al. · Antimicrobial Agents and Chemotherapy · 2012 · 89 citations · Full text

Immunology, Pharmacotherapy, Antimicrobial Chemotherapy +23

Non-Traditional Antibacterial Screening Approaches for the Identification of Novel Inhibitors of the Glyoxylate Shunt in Gram-Negative Pathogens

Kelly Fahnoe, Mark E. Flanagan, Glenn Gibson et al. · PLoS ONE · 2012 · 55 citations · Full text

Bioorganic Chemistry, Antimicrobial Chemotherapy, Bacterial Pathogens +19

Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders

John Malona, Claudio Chuaqui, Boris M. Seletsky et al. · Translational research · 2022 · 40 citations

The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases

Lain‐Yen Hu, Peter A. Boxer, Suzanne R. Kesten et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 32 citations · Full text

Neurodegenerative Diseases, Biochemistry, Medicine +7